Jonathan Allan insider trades: Stoke Therapeutics (STOK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jonathan reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | STOK | ↓ Sell | 627 | $26.33 | $17K | Direct | Oct 2, 2026 (0d) |
| Aug 18, 2026 | STOK | ↓ Sell | 2,861 | $32.03 | $92K | Direct | Aug 18, 2026 (0d) |
| Jun 16, 2026 | STOK | ↓ Sell | 1,457 | $29.95 | $44K | Direct | Jun 18, 2026 (2d) |
| Mar 20, 2026 | STOK | ↓ Sell | 9,293 | $33.69 | $313K | Direct | Mar 24, 2026 (4d) |
| Dec 8, 2025 | STOK | ↓ Sell | 3,978 | $32.28 | $128K | Direct | Dec 10, 2025 (2d) |
| Dec 5, 2025 | STOK | ↓ Sell | 9,803 | $31.25 | $306K | Direct | Dec 5, 2025 (0d) |
| Dec 3, 2025 | STOK | ↓ Sell | 4,576 | $30.22 | $138K | Direct | Dec 3, 2025 (0d) |
| Oct 3, 2025 | STOK | ↓ Sell | 10,000 | $25.07 | $251K | Direct | Oct 7, 2025 (4d) |
| Sep 3, 2025 | STOK | ↓ Sell | 22,117 | $20.11 | $445K | Direct | Sep 3, 2025 (0d) |
| Aug 18, 2025 | STOK | ↓ Sell | 1,683 | $18.24 | $31K | Direct | Aug 20, 2025 (2d) |
| Aug 13, 2025 | STOK | ↓ Sell | 13,712 | $15.00 | $206K | Direct | Aug 15, 2025 (2d) |
| Mar 19, 2025 | STOK | ↓ Sell | 4,211 | $8.49 | $36K | Direct | Mar 20, 2025 (1d) |
| Dec 9, 2024 | STOK | ↓ Sell | 13,666 | $13.61 | $186K | Direct | Dec 11, 2024 (2d) |
| Dec 6, 2024 | STOK | ↓ Sell | 9,696 | $12.78 | $124K | Direct | Dec 10, 2024 (4d) |
| May 20, 2024 | STOK | ↓ Sell | 8,599 | $15.04 | $129K | Direct | May 22, 2024 (2d) |
| Mar 28, 2024 | STOK | ↓ Sell | 5,126 | $13.20 | $68K | Direct | Apr 1, 2024 (4d) |
| Mar 19, 2024 | STOK | ↓ Sell | 2,349 | $6.10 | $14K | Direct | Mar 19, 2024 (0d) |
| Jun 21, 2023 | STOK | ↓ Sell | 1,948 | $13.48 | $26K | Direct | Jun 23, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other STOK insiders
Open-market trades in the last 12 months
About Jonathan Allan's insider trades
Jonathan Allan is General Counsel & Corp Sec at Stoke Therapeutics (STOK). Since Jun 21, 2023, Jonathan has reported no open-market purchases and 18 sales worth $2.6M on SEC Form 4. In the last 12 months: 7 sales ($1.0M).
Their filings also include option exercises (12 filings), grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every STOK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.